Semaglutide: FDA Approved Weight Loss

Semaglutide injections have been approved by the FDA for use as a weight loss treatment. This medication was originally developed as a treatment for type 2 diabetes, but it has been shown to be effective in helping people lose weight as well. In this blog post, we will explore the safety and effectiveness of semaglutide injections for weight loss.

What is Semaglutide?

Semaglutide is a medication that belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. It works by mimicking the effects of a naturally occurring hormone called GLP-1, which helps to regulate blood sugar levels and reduce appetite.

Semaglutide was originally approved by the FDA in 2017 as a treatment for type 2 diabetes. It is administered as a once-weekly injection and has been shown to improve blood sugar control, reduce the risk of cardiovascular events, and promote weight loss in people with diabetes.

More recently, semaglutide has been studied as a treatment for obesity. In June 2021, the FDA approved semaglutide for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, such as high blood pressure or type 2 diabetes.

Effectiveness of Semaglutide for Weight Loss

The effectiveness of semaglutide for weight loss has been demonstrated in several clinical trials. In one study, published in the New England Journal of Medicine, participants who took semaglutide lost an average of 15.3% of their body weight over 68 weeks, compared to 2.6% for those who took a placebo.

Another study, published in Diabetes Care, showed that semaglutide was effective in reducing body weight and improving glycemic control in people with type 2 diabetes who were overweight or obese.

Overall, the studies have shown that semaglutide can help people lose a significant amount of weight and improve their overall health.

Safety of Semaglutide for Weight Loss

Like any medication, semaglutide does carry some potential risks. The most common side effects of semaglutide are gastrointestinal, including nausea, diarrhea, and vomiting. These side effects usually improve over time and can be managed with dietary changes or medication.

There is also a risk of low blood sugar (hypoglycemia) in people with type 2 diabetes who take semaglutide in combination with other diabetes medications. This risk can be minimized by careful monitoring and adjustment of medications as needed.

It is important to note that semaglutide is not recommended for people with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). These conditions increase the risk of developing MTC, a rare but potentially serious type of thyroid cancer.

In addition, semaglutide may interact with other medications, so it is important to inform your doctor of all medications you are taking before starting treatment.

Conclusion

Semaglutide is a medication that has been shown to be effective in promoting weight loss and improving overall health. Like any medication, it does carry some potential risks, but these risks can be minimized with careful monitoring and management.

If you are interested in using semaglutide for weight loss, talk to your doctor to determine if it is right for you. They can help you weigh the potential benefits and risks and develop a treatment plan that is tailored to your individual needs.

New price reductions on Wegovy® 

How Do I Know If I Qualify for Semaglutide?

We have many different options for patients struggling to lose weight, if you do not qualify for a GLP medication, we would be happy to go over all of your potential options to help you reach your goals.